Seer Inc (SEER)

Seer Inc (SEER) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $121M; returns 1 day +0.0%, 1 week -3.0%, 1 year -9.2%.

Seer, Inc. (SEER) is a life sciences company focused on pioneering next-generation proteomics, specifically the large-scale study of proteins and their functions. Their primary offering is the Proteograph Product Suite, which combines engineered nanoparticle assays with mass spectrometry and bioinformatics to enable high-throughput, unbiased protein analysis from biological samples.

Groups SEER belongs to

• Life Sciences Tools & Services
• Life Sciences
• Biotechnology
• Healthcare
• Mass Spectrometry
• R&D

SEER financial model: income statement, cash flow and balance sheet